Gastroesophageal Reflux Disease (GERD) is a chronic condition characterized by the retrograde flow of gastric contents into the esophagus, leading to symptoms such as heartburn, regurgitation, and potential esophageal injury. The pathophysiology of GERD primarily involves dysfunction of the lower esophageal sphincter (LES), impaired esophageal clearance, delayed gastric emptying, and transient LES relaxations. Additional contributing factors include hiatal hernia and obesity. The pharmacological management of GERD focuses on acid suppression and includes the use of proton pump inhibitors (PPIs), H2-receptor antagonists, antacids, and prokinetic agents. While PPIs remain the mainstay of treatment due to their superior efficacy, concerns about long-term use necessitate consideration of alternative strategies. Nonpharmacological interventions, such as lifestyle and dietary modifications: weight loss, head-of-bed elevation, and avoidance of trigger foods: play a critical role in symptom control and disease management. This review explores the underlying mechanisms of GERD, evaluates current pharmacologic therapies, and highlights the importance of holistic, nonpharmacologic approaches in the comprehensive management of the disease.
Akhilesh Kumar Kuril (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: